Inhibition of STAT3 expression via chemically modified siRNA's enhances the effects of cisplatin in the parental and resistant Calu1 non-small cell lung cancer cells

dc.contributor.authorCetintas, V. B.
dc.contributor.authorKaymaz, B. T.
dc.contributor.authorEroglu, Z.
dc.contributor.authorKosova, B.
dc.date.accessioned2019-10-27T21:51:53Z
dc.date.available2019-10-27T21:51:53Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) -- JUL 06-11, 2013 -- Saint Petersburg, RUSSIAen_US
dc.description.sponsorshipFederat European Biochemical Socen_US
dc.identifier.endpage82en_US
dc.identifier.issn1742-464X
dc.identifier.issn1742-4658
dc.identifier.startpage82en_US
dc.identifier.urihttps://hdl.handle.net/11454/47346
dc.identifier.volume280en_US
dc.identifier.wosWOS:000325919200264en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofFebs Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleInhibition of STAT3 expression via chemically modified siRNA's enhances the effects of cisplatin in the parental and resistant Calu1 non-small cell lung cancer cellsen_US
dc.typeConference Objecten_US

Dosyalar